Last updated 18 June 2026. Educational content, not medical advice. NAD+ is available as a compounded prescription through licensed telehealth providers. Talk to a licensed clinician before starting any injectable therapy.
Short answer: The most common clinical starting point for injectable NAD+ is 100 mg subcutaneously two to three times a week, reconstituted from a 500 mg lyophilized vial at 100 mg/mL using 5 mL bacteriostatic water. IV loading phases at 250 to 500 mg per session run $400 to $800 per infusion and require clinic supervision. Nasal spray (30 mg daily) and oral NMN precursors (500 to 1,000 mg daily) are the self-administered tier below that. The route you pick dictates everything: speed of effect, side effect profile, cost, and whether you need a prescription at all.
Why does everybody suddenly want to take NAD+?
The short version: your body runs low on it faster than most people realize, and the symptoms of that depletion look a lot like “just getting older.”
NAD+ (nicotinamide adenine dinucleotide) is the coenzyme your cells use to convert food into ATP, repair DNA through PARP enzymes, and activate the sirtuin proteins that regulate stress response and metabolic flexibility. When it drops, everything from energy production to cellular cleanup slows down.
The drop is not subtle. Tissue NAD+ levels decline by roughly 50% between your 20s and your 50s, based on human skin and liver biopsies and brain MRI studies published in a 2020 PMC review by McReynolds, Chellappa, and Baur at Princeton and Penn. The primary driver is an enzyme called CD38, whose expression rises with age and consumes NAD+ faster than the salvage pathway can rebuild it. A secondary driver is declining expression of NAMPT, the rate-limiting enzyme in NAD+ synthesis, which has been documented in aging adipose tissue, skeletal muscle, and brain regions.
Important nuance: whole-blood NAD+ does not reliably decline with age in cross-sectional studies. The decline shows up in tissues, which is why a whole-blood panel is not the right test here, and why the Jinfiniti intracellular NAD test ($198 for a single finger-prick CLIA-certified test) measures intracellular levels inside red blood cells rather than serum.
Full-body lab membership: 100+ biomarkers, doctor-reviewed, tracked over time.
What are the actual delivery routes, and how do they differ?
“Taking NAD+” covers four genuinely different interventions. They share a molecule but diverge sharply on bioavailability, onset, side effects, cost, and whether you can self-administer. Here is the honest map:
| Route | Starting dose | Bioavailability | Onset | Cost per dose | Prescription needed? |
|---|---|---|---|---|---|
| IV infusion | 250-500 mg over 2-4 hrs | ~100% (direct bloodstream) | Minutes (during drip) | $300-$800/session | Yes (clinic) |
| Subcutaneous injection | 50-100 mg, 2-3x/week | High, bypasses GI | 30-90 min | $105-$350/month | Yes (telehealth) |
| Nasal spray | 30 mg once daily | Moderate (mucosal) | 10-20 min peak | $60-$150/month | Varies (some OTC, some Rx) |
| Oral NMN or NR precursors | 500-1,000 mg daily | Variable, GI-dependent | Hours (indirect) | $40-$100/month | No (supplement) |
IV infusion delivers the highest peak but requires clinic supervision and a 90 to 120-minute chair time, confirmed by Modal Pain Management’s NYC protocol, which uses 250 mg at $400 and 500 mg at $500. Subcutaneous injection sits below IV in peak levels but offers the best balance of bioavailability and self-management convenience. Nasal spray reaches peak plasma levels within 10 to 20 minutes and has roughly 30% better bioavailability than oral routes, due to rich vascular mucosa and bypassing first-pass liver metabolism, but it carries the lowest dose ceiling. Oral NMN and NR require conversion through the salvage pathway and show meaningful but highly variable NAD+ elevation depending on gut health, age, and genetics.
Do not make the mistake of comparing route cost without counting what each route does and does not include. An IV session at $500 includes clinical monitoring, nursing time, a physician on-site, and infusion supplies. A 500 mg subcutaneous vial for $80 requires you to reconstitute, calculate, inject, and troubleshoot any reaction yourself.
How does subcutaneous NAD+ injection actually work? (what the product pages skip)
A subcutaneous NAD+ vial arrives lyophilized, meaning freeze-dried to a white powder. The molecule cannot ship stable in solution, so you mix it yourself before each session. The standard protocol from TrimRX’s reconstitution guide and multiple compounding pharmacy SOPs is:
- Add 5 mL bacteriostatic water (BAC water, 0.9% benzyl alcohol) to a 500 mg vial. This yields a concentration of 100 mg/mL.
- Inject the water slowly down the inside glass wall of the vial, not directly onto the powder, to avoid denaturing the peptide. Do not shake; swirl gently.
- The reconstituted solution is stable for 14 days refrigerated at 2 to 8 degrees Celsius, not 28 days. NAD+ in BAC water degrades faster than most other peptides.
- Withdraw your dose with a U-100 insulin syringe. At 100 mg/mL: 10 units (0.10 mL) = 10 mg, 50 units (0.50 mL) = 50 mg, 100 units (1.0 mL) = 100 mg.
- Inject subcutaneously into the abdomen or thigh, rotating sites each session.
The single most important thing nobody says upfront: NAD+ stings more than any other peptide in common use. The mechanism is well-documented. NAD+ is acidic, and that acidity irritates subcutaneous nerve endings and surrounding tissue on contact. It also activates the GPR109A receptor (the same niacin flush receptor), which triggers prostaglandin release causing warmth, local flushing, and sometimes a brief hot sensation radiating outward from the site. None of this is dangerous, but it is genuinely unpleasant for about 60 to 90 seconds.
Practical mitigation that actually works: inject slowly over 10 to 15 seconds rather than in one push. Ice the site for 10 minutes beforehand to constrict nerve sensitivity. Do not inject into the same spot two sessions in a row. The discomfort typically peaks at 30 seconds and resolves within two to three minutes at subcutaneous doses, per clinical reports from Jinfiniti’s side effects overview and PerfectB’s injection guide.
Personally, the stinging is the most underreported aspect of NAD+ self-injection. You will find plenty of social media posts showing someone effortlessly injecting BPC-157 or CJC-1295 with no reaction. NAD+ is a different experience entirely, and the first time it catches you off guard.
What is the real dosing range, and how does a loading phase work?
The doses in circulation range from 50 mg to 1,000 mg per session depending on route, and the spread can be confusing without context. Here is how clinical practice actually structures it, based on protocols from South Lake Pharmacy’s compounding guide and telehealth operators publishing detailed SOP:
Subcutaneous starting protocol:
– Week 1 to 2: 50 mg every other day (assess tolerance, the stinging reaction, and any systemic flush response)
– Week 3 to 4: increase to 100 mg per session if well-tolerated
– Maintenance: 100 mg two to three times weekly, ongoing
IV loading protocol:
– Phase 1 (weeks 1 to 4): 4 to 6 sessions of 250 to 500 mg, each over 2 to 4 hours
– Phase 2 (maintenance): one session every 4 to 8 weeks, dose calibrated to symptom response and any repeat intracellular testing
Nasal spray:
– One to two sprays per nostril once daily, yielding approximately 30 mg total
– Often used between injectable sessions as a bridging dose rather than a standalone protocol
The IV side effect profile is notably different from subcutaneous. Nausea, chest tightness, rapid heartbeat, and flushing during IV infusion are rate-dependent phenomena: when infusion is slowed, they recede. The mechanism is the same prostaglandin release but accelerated by the direct IV delivery. Clinics routinely slow or pause infusions in response to patient feedback. These symptoms are not rare or unusual; they are expected with faster rates and generally resolve once the drip is adjusted.
Myth to break: “higher dose always means better results.” The research does not support dose escalation for wellness endpoints. A 2025 randomized controlled trial published in eClinicalMedicine (The Lancet) used 2,000 mg/day of oral NR in long COVID patients for 20 weeks and found within-group improvements in fatigue severity, depressive symptoms, and sleep quality but no statistically significant between-group differences versus placebo. Larger doses did not produce cleaner data. The honest state of the science is that NAD+ supplementation appears safe across every tested protocol and shows promise for specific populations, but dose-response relationships in humans are not clearly established yet.
IV vs subcutaneous vs nasal spray: which one should you actually use?
The answer depends entirely on what you are trying to accomplish and what your life allows for.
IV infusion is the right choice if: you are doing an initial loading phase, managing a specific acute condition (addiction recovery, post-viral fatigue, perioperative support), or working with a clinic that monitors labs during therapy. The cost is real: $250 to $800 per session at most US clinics, with geographic variation (NYC and LA run $600 to $1,000+ per session for 500 mg, per PeptideDeck’s IV therapy overview), and none of it covered by insurance. HSA/FSA funds can sometimes apply.
Subcutaneous injection is the right choice if: you want the bioavailability advantage over oral precursors, you are comfortable with at-home injection (you have already been managing another peptide protocol), and you have a telehealth prescription. Cost runs $105 to $350 per month through licensed providers, far below IV, with labs and monitoring factored into most program fees.
Nasal spray is the right choice if: you want a daily maintenance route between injection sessions, you want rapid CNS-adjacent delivery (the nasal mucosa sits close to the blood-brain barrier and peak plasma is 10 to 20 minutes, per Synchronicity Health’s guide), or you want to avoid injections entirely. Eden, ProHealth Longevity, and Hydramed all offer NAD+ nasal sprays at various prescription and OTC tiers. The ceiling is low though: at 30 mg per day you are not going to replicate what a 500 mg IV session does.
Oral NMN or NR is the right choice if: you want a low-cost, no-needle starting point to see whether NAD+ supplementation changes anything for you. NMN at 500 mg/day raised blood NAD+ levels in a 2021 trial that found improved muscle insulin sensitivity in women with prediabetes (referenced in GetHealthspan’s review). NMN and NR supplements are sold openly as dietary supplements, cost $40 to $100 per month from brands like Tru Niagen (NR) or DoNotAge (NMN), and require no prescription. The trade-off is inconsistent absorption and a 2 to 4-hour indirect conversion time versus the 10 to 20-minute plasma peak of nasal spray or the near-immediate IV rise.
Do not believe the claim that “injections are 10x more effective than oral.” No published human trial has established that ratio for clinical outcomes. The pharmacokinetic advantage of injections is real and documented; whether that translates to proportionally better outcomes in healthy adults is an open question.
Telehealth GLP-1 program with provider visits and pharmacy coordination.
Why NAD+ is not like other peptides (the compliance problem nobody talks about)
Most injectable peptides in the longevity space are straightforward once you learn the reconstitution math. NAD+ has a compliance problem that rarely gets mentioned in forum guides, and it explains a lot of the inconsistent self-reported results.
First, the stinging. As covered above, it is real, it is dose-proportional, and it gets old fast. The people who report consistent 2x to 3x weekly subcutaneous protocols for months are outliers in terms of pain tolerance or technique, not the median experience.
Second, the reconstituted solution’s 14-day stability window is genuinely shorter than most people expect. If you reconstitute a 500 mg vial on Monday and use 100 mg sessions Monday-Wednesday-Friday, you use 300 mg in week one and have 200 mg left. By day 14, you must discard whatever remains. Over 12 months that means roughly 26 vials, not the 20 sessions-per-vial math that seems obvious at first. Factor that into your cost projection.
Third, food-grade NAD+ is not appropriate for sterile injection. The FDA flagged this explicitly: compounders have sourced nicotinamide adenine dinucleotide labeled as food-grade from repackagers, and that classification means it has not been processed to eliminate microbes and endotoxins suitable for injectables. The FDA has received adverse event reports including severe chills, vomiting, and hospitalization from improperly sourced compounded NAD+ injectables, per the FDA’s human drug compounding guidance. This is precisely why sourcing from a named, licensed 503A compounding pharmacy (not a research-chemical vendor selling lyophilized powder) matters more for NAD+ than for most other compounds.
If a telehealth provider cannot name their compounding pharmacy and confirm it is 503A licensed, that is a red flag worth walking away from.
Who actually benefits from NAD+ therapy? (the honest short list)
The research is most credible, and most clinicians are most confident, in three populations:
Adults over 40 with documented fatigue, metabolic dysfunction, or post-viral symptoms. This covers the largest share of people seeking NAD+ therapy. The mechanism is plausible (tissue NAD+ decline is well-documented in this age group), the safety profile is established, and the subjective reports of improved energy and cognitive clarity are consistent enough across clinic populations to be taken seriously even before large RCTs land.
People in addiction recovery. IV NAD+ has the longest clinical history of any indication, with protocols going back decades in addiction medicine. It has been used off-label to reduce withdrawal intensity and cravings, and multiple addiction-medicine clinics treat it as a standard adjunct. This is not speculative; it is the oldest clinical use.
Long COVID patients with persistent fatigue and brain fog. A 58-person randomized controlled trial of 2,000 mg/day oral NR over 20 weeks, published December 2025 in eClinicalMedicine, found significant within-group improvements in fatigue severity, sleep quality, and executive function in the NR arm, though between-group statistical significance was not achieved at this sample size. Larger trials are underway. The signal is real enough that several long COVID clinics, including Clarus Health in San Francisco, now include NAD+ as part of their standard protocol alongside other interventions.
For healthy adults under 40 with no specific complaint, the honest answer is: the evidence does not yet support routine injectable NAD+ as a wellness intervention. Oral NMN or NR is a reasonable low-risk experiment; IV therapy at $500 a session for someone with no identified deficiency or functional complaint is harder to justify with current data.
How much does NAD+ therapy cost in 2026?
Pricing splits cleanly by route and access model.
IV therapy in a clinic: $250 to $800 per single session. Mid-size cities average $300 to $500 for a 500 mg infusion. NYC and LA run $600 to $1,000+. Loading phases of 4 to 6 sessions before maintenance means an initial investment of $1,500 to $4,800.
Subcutaneous via telehealth: $105 to $350 per month, monitoring included, based on data from VaccineAlliance’s NAD cost overview. This typically includes the compounded NAD+ vials, supplies, and the telehealth platform’s care coordination.
Nasal spray (Rx or OTC): $60 to $150 per month from providers like Eden, ProHealth, or Hydramed, depending on concentration and whether a prescription is involved.
Oral NMN/NR supplements: $40 to $100 per month. Tru Niagen NR (ChromaDex) at 300 to 600 mg daily runs roughly $40 to $60. DoNotAge NMN at 500 mg daily runs about $50. Third-party tested, NSF or Informed Sport certification is worth checking for this tier.
Intracellular NAD+ test (Jinfiniti): $198 single test, $673 for a pack of four, optimal range 40 to 100 micromolar. Running a baseline test, then a retest at 4 weeks, before and after your chosen protocol, converts a guessing game into data.
None of these are covered by insurance. NAD+ therapy is classified as elective and wellness-based regardless of clinical rationale. Budget accordingly before you start, and do not let a low first-dose price mislead you about total program cost.
When should you NOT start NAD+ therapy? (and common mistakes to avoid)
There are genuine contraindications and misuses worth flagging:
Known active malignancy. NAD+ supports cell repair and sirtuin activity, and there is theoretical concern (not yet proven in humans at supplementation doses) that it could support energy availability in rapidly dividing cancer cells. Most oncology-informed clinicians pause NAD+ supplementation during active cancer treatment pending clearer data.
Starting without a baseline test. If your intracellular NAD+ is already in the optimal range (40 to 100 µM), paying for IV loading sessions has no clear mechanistic rationale. Test first.
Injecting food-grade or research-chemical powder. As noted above, this is the single biggest safety risk in the self-administration tier. The FDA’s adverse event reports on compounded NAD+ involving severe chills, vomiting, and hospitalization trace back to improper sourcing, not the molecule itself.
Ignoring the 14-day stability window and injecting degraded solution. Discolored NAD+ solution (yellowing, clouding) is degraded. Discard it; do not inject it.
Using injections to replace rather than complement a licensed clinical protocol. The telehealth route exists, it is accessible, and it is not dramatically more expensive than grey-market self-sourcing when you count supplies, testing, and waste. The difference is a clinician adjusting your protocol when something is not working, which matters more than most people anticipate.
Frequently asked questions
How much NAD+ should I inject per day?
The standard subcutaneous maintenance dose is 100 mg per session, two to three times weekly, not daily, per the clinical protocols published by South Lake Pharmacy and PeptideDosingProtocols.com. Daily injection is used only in short loading phases of 7 to 14 days. An IV session is typically 250 to 500 mg and is not given daily; loading involves 4 to 6 sessions over 2 to 4 weeks, then maintenance every 4 to 8 weeks.
Why does NAD+ injection sting so much?
NAD+ is acidic and irritates subcutaneous nerve endings at the injection site. It also activates the GPR109A receptor, triggering prostaglandin release that causes localized warmth and flushing. The sting peaks around 30 seconds and resolves within 2 to 3 minutes. Slowing the injection (push over 10 to 15 seconds) and icing the site beforehand significantly reduce the reaction.
Can I take oral NMN instead of injecting NAD+ directly?
Yes, and for many people it is the right starting point. NMN and NR are precursor molecules the body converts to NAD+ after absorption. They do not require a prescription or injection. The trade-off is slower and more variable absorption; a 2021 NMN clinical trial found improved insulin sensitivity in prediabetic women at 1,000 mg/day, but individual response varies widely based on gut health and age. If an intracellular test shows you are deficient and oral supplementation does not move your numbers after 8 to 12 weeks, injectable is the logical next step.
How long before NAD+ injections start working?
Acute effects (energy, mental clarity) are often reported within 24 to 72 hours of the first injection. Sustained changes in metabolic markers, recovery, and cognitive function are typically assessed at 4 to 6 weeks. Running a repeat intracellular NAD+ test at 4 weeks is the most objective way to confirm your levels are actually rising.
Is NAD+ available through telehealth in 2026?
Yes, through licensed providers like Defy Medical, Marek Health, and OneTwenty (launched June 2026). NAD+ is not a controlled substance, so telehealth prescribing of non-controlled medications is governed by state pharmacy board rules rather than DEA flexibilities, per Telehealth.HHS.gov. Most telehealth providers require an intake evaluation and baseline labs before issuing a compounding pharmacy prescription.
What is the difference between NAD+ and NMN?
NAD+ is the active coenzyme itself. NMN (nicotinamide mononucleotide) is a precursor that the body converts to NAD+ via the SLC12A8 transporter and the salvage pathway. Injected NAD+ bypasses that conversion step and raises plasma levels faster and more predictably. NMN’s advantage is oral bioavailability and no needle. Neither has been proven superior for clinical outcomes in head-to-head human RCTs.
What should I do if I experience chest tightness during NAD+ IV therapy?
Tell the nurse or clinician immediately. Chest tightness during IV NAD+ infusion is rate-dependent and resolves when the infusion is slowed or paused. It is a recognized, expected response to rapid infusion speed, not an allergic reaction. The clinic will slow the drip and the sensation typically passes within minutes. This is precisely why IV NAD+ requires clinical supervision and should not be self-administered.
Telehealth GLP-1 program with provider visits and pharmacy coordination.
Author: Vital Signs Today Editorial Team, [credential]”]. Educational content, not medical advice. Sources linked inline.
Primary sources:
– McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Free Radic Biol Med. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7442590/
– Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. eClinicalMedicine (The Lancet). 2025. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00567-X/fulltext
– FDA. Human Drug Compounding Policies and Rules. https://www.fda.gov/drugs/human-drug-compounding/human-drug-compounding-policies-and-rules
– GetHealthspan. NAD+ Injections vs. Oral Supplements: What the Evidence Actually Shows. https://www.gethealthspan.com/research/article/nad-injections-benefits
– Jinfiniti Precision Medicine. Intracellular NAD+ Test. https://www.jinfiniti.com/product/intracellular-nad-test/
– Modal Pain Management. NAD+ IV Therapy: Benefits, Cost & What to Expect. https://modalpain.com/blog/nad-iv-therapy-benefits-cost-what-to-expect/
– TrimRX. NAD+ Reconstitution Guide. https://trimrx.com/blog/nad-reconstitution/
– PeptideDosingProtocols.com. NAD+ Protocol Guide (2026). https://www.peptidedosingprotocols.com/protocol/nad-plus
– Jinfiniti. NAD Injections Side Effects. https://www.jinfiniti.com/nad-injections-side-effects/
– OneTwenty. Best Peptide Companies: How to Get Legal Peptides Online. https://onetwenty.com/blog/peptide-companies
– Synchronicity Health. NAD+ Nasal Spray Dosage Guide. https://synchronicity.health/blogs/news/nad-nasal-spray-dosage-guide-how-to-use-benefits-and-safety-for-optimal-results
